help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on September 11, 2003
Endocrinology, doi:10.1210/en.2003-0592
A more recent version of this article appeared on December 1, 2003
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
144/12/5402    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keeton, A. B.
Right arrow Articles by Messina, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keeton, A. B.
Right arrow Articles by Messina, J. L.

Submitted on May 14, 2003
Accepted on August 26, 2003

INSULIN REGULATED EXPRESSION OF EGR-1 AND KROX20: DEPENDENCE ON ERK1/2 AND INTERACTION WITH P38 AND PI3-KINASE PATHWAYS

Adam B. Keeton1, Katherine D. Bortoff1, William L. Bennett1, J. Lee Franklin1, Derwei Y. Venable1, and Joseph L. Messina1*

1 Department of Pathology, Division of Molecular and Cellular Pathology, University of Alabama at Birmingham, Birmingham AL, 35294-0019

* To whom correspondence should be addressed. E-mail: messina{at}path.uab.edu.

In addition to its ability to rapidly alter metabolism, insulin is also able to regulate the expression of numerous genes via activation of the PI3-Kinase, MEK-ERK, or p38 pathways. Using differential screening of H4IIE cells, we have identified two members of the Egr zinc-finger transcription factor family of early response genes, Egr-1 and Krox20, whose transcription is induced by insulin treatment. Egr-1 may be involved in insulin's regulation of hepatic gene expression. Krox20 regulation and expression has been primarily studied in neural cells and tissues, but little has been previously reported on the presence of Krox20 in cells of hepatic origin, or its regulation by insulin. In the present studies, insulin treatment rapidly increased transcription of both Egr-1 and Krox20. In cells pretreated with a PI3-K inhibitor, there was no reduction in the effect of insulin on Egr-1 and Krox20, but an increase in Egr-1 transcription. The rapid induction of ERK1/2 phosphorylation was completely blocked by pretreatment with a MEK1 inhibitor and was associated with a nearly complete inhibition of insulin-stimulated induction of both Egr-1and Krox20, indicating this pathway is necessary for insulin's effect on these genes. Finally, inhibition of the p38 pathway, followed by insulin addition, caused an additive induction of both Egr-1and Krox20. In conclusion, these genes are induced by insulin via coordinated regulation of the MEK-ERK and p38 pathways, and in the case of Egr-1, the PI3-Kinase pathway.


Key words: Insulin • Egr-1 • Krox20 • Gene Expression • ERK







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society